期刊文献+

槲皮素-7-硫酸酯钠盐对重组人蛋白激酶CK2全酶的影响 被引量:4

Effects of sodium quercetin-7-sulfate on recombinant human protein kinase CK2 holoenzyme
下载PDF
导出
摘要 目的 观察槲皮素 7 硫酸酯钠盐 (SQMS)对重组人CK2全酶的直接作用及酶动力学机制。方法 通过测定转移到CK2底物上的 [γ 3 2 P]ATP的 [3 2 P]放射活度检测不同条件下的重组人CK2全酶的活性。结果 SQMS对重组人CK2全酶有很强的抑制作用 ,IC50 为 1 37μmol·L-1。CK2的动力学研究表明 :SQMS与ATP和酪蛋白分别呈竞争性和非竞争性抑制作用。结论 SQMS是CK2的抑制剂 ,SQMS的抑制作用与ATP呈竞争性。 AIM To study the effects and kinetics of sodium quercetin 7 sulphate (SQMS) on recombinant human protein kinase CK2 holoenzyme. METHODS The recombinant human CK2 holoenzyme activity was assayed by detecting incorporation of 32 P of [γ 32 P]ATP into the substrate at various conditions. RESULTS SQMS was shown to strongly inhibit the holoenzyme activity of recombinant human protein kinase CK2 with an IC 50 of 1 37 μmol·L -1 , Kinetic studies of SQMS on recombinant human CK2 showed: the inhibition was competitive with ATP and noncompetitive with casein. CONCLUSIONSQMS is an inhibitor of protein kinase CK2, and the inhibitory action of SQMS on CK2 is competitive with ATP and noncompetitive with casein.
出处 《中国药理学通报》 CAS CSCD 北大核心 2002年第3期315-318,共4页 Chinese Pharmacological Bulletin
基金 广东省自然科学基金资助课题 No 0 11766 广东医学院标志性成果扶持课题NoXK0 0 0 2
关键词 蛋白激酶CK2 重组蛋白 全酶 槲皮素 衍生物 酶动力学 protein kinase CK2 recombinant protein holoenzyme quercetin derivatives enzyme kinetics
  • 相关文献

参考文献8

二级参考文献22

共引文献92

同被引文献46

  • 1刘文,梁念慈.槲皮素-7-硫酸酯钠盐对重组人肌醇磷脂3-激酶p110β催化亚基的影响[J].中国药理学通报,2005,21(3):355-357. 被引量:4
  • 2刘晓婷,蔺新英.豆豉激酶对实验性小鼠体内血栓形成的影响[J].食品与药品,2006,8(06A):39-41. 被引量:6
  • 3李鹤,郝晓元,雷田香,苏云.中药抗血栓的实验研究进展[J].湖南中医学院学报,2006,26(3):63-64. 被引量:19
  • 4Liu W, Song Z J, Liang NC, et al. Inhibitory effects of sodium quercetin monosulfate on pig platelet aggregation induced by thrombin. Aeta Pharrnacol Sin ,1999; 20(7): 623 -626.
  • 5Cantley LC.The Phosphoinositide 3-Kinase Pathway[J].Science,2002,296(31):1655-7.
  • 6Wymann MP, Zvelebil M, Laffargue M. Phosphoinositide 3-kinase signalling--which way to target[J].Trends in Pharmacological Sciences,2003,24(7): 366-76.
  • 7Ward SG,Finan P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents[J].Current Opinion in Pharmacology,2003,3(3):426-34.
  • 8Stein RC, Waterfield MD. PI3-kinase inhibition: a target for drug development[J].Mol Med Today,2000,6(9):347-57.
  • 9Stein RC. Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment[J].Endocrine-Related Cancer,2001,8(8):237-48.
  • 10Agullo G, Gamet-Payrastre L, Manenti S et al.Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition[J].Biochemical Pharmacology,1997,53(12):1649-57.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部